TOKYO -- Takeda Pharmaceutical has high hopes for China, India and Southeast Asia, as Japan's largest drugmaker looks to further extend its international reach, CEO Christophe Weber said in an interview on Tuesday.
"Asia is a high priority for us," Weber said on the sidelines of the Nikkei Global Management Forum. "With 3 billion people, health care demand is strong and countries like China and India are big potential markets."
